Shalby
234.11
+2.75(+1.19%)
Market Cap₹2,528.62 Cr
PE Ratio357.67
Company Performance:
1D+1.19%
1M+15.43%
6M+15.37%
1Y-16.98%
5Y+198.61%
View Company Insightsright
More news about Shalby
08Jul 25
Shalby Partners with SVVV Indore to Launch Healthcare Management Programs
Shalby Ltd has announced a strategic partnership with Shri Vaishnav Vidyapeeth Vishwavidyalaya (SVVV) in Indore to introduce healthcare management programs. The collaboration aims to bridge the gap between academic education and practical healthcare management skills. The partnership will focus on introducing specialized healthcare management programs, enhancing skills of future healthcare professionals, and providing industry-tailored education. This initiative is expected to contribute to skill development, foster industry-academia collaboration, and address the growing demand for skilled professionals in healthcare management.
20Jun 25
Shalby's Unit Secures International Accreditation from AACI America LLC
A unit of Shalby Limited has been accredited by AACI America LLC, an internationally recognized accrediting body. This accreditation signifies the unit's adherence to high-quality standards in healthcare delivery, including patient safety, quality of care, and operational efficiency. The recognition is expected to enhance Shalby's reputation, potentially attract international patients, and strengthen its position in the competitive healthcare market.
30May 25
Shalby Ltd Reports Widening Q4 Losses and Declining Margins
Shalby Ltd, a healthcare provider, released Q4 financial results showing increased losses and decreased revenue. The company reported a loss of ₹11.82 crore, up from ₹5.75 crore in Q3. Revenue fell to ₹265.00 crore from ₹276.00 crore. EBITDA decreased to ₹20.80 crore with margins narrowing to 7.90%. For the full fiscal year, revenue increased to ₹1,087.00 crore, but the company reported an annual loss of ₹0.70 crore. Following the announcement, Shalby's shares declined by 5.40%.
29May 25
Shalby Reports Mixed Q4 Results: Net Loss Narrows, Revenue Grows, but EBITDA Declines
Shalby Ltd. reported a 6.56% year-over-year revenue increase to ₹260.00 crore in Q4. Net loss narrowed to ₹11.00 crore from ₹16.60 crore last year. However, EBITDA declined 46.27% to ₹20.90 crore, with EBITDA margin falling to 7.89% from 15.93%. Sequential performance showed increased losses compared to the previous quarter.
25Mar 25
Shalby Ltd Terminates Franchise Agreement with Divine Super Specialty Hospital in Ranchi
Shalby Limited has terminated its franchise agreement with Divine Super Specialty Hospital Private Limited in Ranchi due to multiple breaches of terms and conditions. The termination notice was issued on March 25, 2025. Shalby asserts that this decision will not significantly impact its financial position. Separately, the company announced a trading window closure for insiders from April 1, 2025, until 48 hours after the declaration of the Audited Financial Results for Q4 and FY 2024-25.
Shalby
234.11
+2.75
(+1.19%)
1 Year Returns:-16.98%
Industry Peers
Max Healthcare Institute
1,180.70
(+2.41%)
Apollo Hospitals
7,929.00
(+1.32%)
Fortis Healthcare
967.15
(+1.85%)
Global Health
1,370.60
(-0.52%)
Narayana Hrudayalaya
1,782.40
(+2.13%)
Aster DM Healthcare
642.35
(+0.21%)